Androgenetic Alopecia Treatment Market Size, Trends, Outlook, Insights, Overview 2024-2033

Androgenetic alopecia, also known as male-pattern baldness or female-pattern hair loss, is a common form of hair loss in both men and women. It is characterized by a progressive thinning of the hair, typically starting with a receding hairline in men and diffuse thinning over the crown in women. This condition is influenced by genetic factors and the presence of androgens, particularly dihydrotestosterone (DHT). Sizing and Forecast The androgenetic alopecia treatment market size has grown strongly in recent years. It will grow from $2.13 billion in 2023 to $2.29 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%.  The  growth in the historic period can be attributed to emphasis on improving patient outcomes and quality of life, increase in the geriatric population, increasing healthcare expenditure. The androgenetic alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.  The growth in the forecast period can be attributed to rising incidence of hair loss, prevalence of chronic diseases such as cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis, demand for effective solutions to address hair loss concerns. Major trends in the forecast period include partnerships, product approvals, investments, research and developments. Order your report now for swift delivery, visit the link: https://www.thebusinessresearchcompany.com/report/androgenetic-alopecia-treatment-global-market-report Segmentation & Regional Insights The androgenetic alopecia treatment market covered in this report is segmented – 1) By Treatment Type: Pharmaceutical, Device 2) By Medication Type:  Prescription, Over-The-Counter 3) By Gender: Male, Female 4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users North America was the largest region in the androgenetic alopecia treatment market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Intrigued to explore the contents? Secure your hands-on a free sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=15721&type=smp Major Driver Impacting Market Growth The rising hair loss cases are expected to propel the growth of the androgenetic alopecia treatment market going forward. Hair loss or alopecia refers to the partial or complete loss of hair from the scalp or other body parts. Hair loss cases are related to nutritional deficiencies, hormonal changes, genetics, and increased stress. Androgenetic alopecia treatments work through various mechanisms, including hormonal regulation, follicle stimulation, and surgical restoration, to manage hair loss and promote regrowth. For instance, in March 2022, according to an article by the Hair Society, a US-based full-service professional organization, hair loss affected about 21 million women and 35 million men globally. Moreover, in 2024, according to the National Health Service, a UK-based government agency, approximately 8 million women and 6.5 million men are affected by hair loss in the UK. Additionally, more than 650,000 hair transplants are carried out each year. Therefore, rising hair loss cases drive the androgenetic alopecia treatment market. Key Industry Players Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy's Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc. The androgenetic alopecia treatment market report table of contents includes: 1. Executive Summary 2. Androgenetic Alopecia Treatment Market Characteristics 3. Androgenetic Alopecia Treatment Market Trends And Strategies 4. Androgenetic Alopecia Treatment Market - Macro Economic Scenario 5. Global Androgenetic Alopecia Treatment Market Size and Growth … 32. Global Androgenetic Alopecia Treatment Market Competitive Benchmarking 33. Global Androgenetic Alopecia Treatment Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Androgenetic Alopecia Treatment Market 35.Androgenetic Alopecia Treatment Market Future Outlook and Potential Analysis 36. Appendix Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow Us On: LinkedIn: ht